AU2001292905A1 - Method of identifying osteoregenerative agents using differential gene expression - Google Patents
Method of identifying osteoregenerative agents using differential gene expressionInfo
- Publication number
- AU2001292905A1 AU2001292905A1 AU2001292905A AU9290501A AU2001292905A1 AU 2001292905 A1 AU2001292905 A1 AU 2001292905A1 AU 2001292905 A AU2001292905 A AU 2001292905A AU 9290501 A AU9290501 A AU 9290501A AU 2001292905 A1 AU2001292905 A1 AU 2001292905A1
- Authority
- AU
- Australia
- Prior art keywords
- osteoregenerative
- identifying
- agents
- gene expression
- differential gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Physiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23357900P | 2000-09-19 | 2000-09-19 | |
US60/233,579 | 2000-09-19 | ||
PCT/US2001/029548 WO2002024943A2 (en) | 2000-09-19 | 2001-09-19 | Method of identifying osteoregenerative agents using differential gene expression |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001292905A1 true AU2001292905A1 (en) | 2002-04-02 |
Family
ID=22877817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001292905A Abandoned AU2001292905A1 (en) | 2000-09-19 | 2001-09-19 | Method of identifying osteoregenerative agents using differential gene expression |
Country Status (3)
Country | Link |
---|---|
US (1) | US20030091973A1 (en) |
AU (1) | AU2001292905A1 (en) |
WO (1) | WO2002024943A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2546111A1 (en) * | 2003-11-25 | 2005-06-16 | Novartis Ag | Biomarkers for the efficacy of calcitonin and parathyroid hormone treatment |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1075491B1 (en) * | 1998-05-05 | 2008-04-16 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Pth2 receptor selective compounds |
AU749288B2 (en) * | 1998-09-04 | 2002-06-20 | Aventis Pharmaceuticals Inc. | Luciferase reporter bioassay of parathyroid hormone compounds |
WO2000029846A2 (en) * | 1998-11-13 | 2000-05-25 | Curagen Corporation | COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY |
AU1918300A (en) * | 1998-11-25 | 2000-06-13 | General Hospital Corporation, The | Amino-terminal modified parathyroid hormone (pth) analogs |
-
2001
- 2001-09-19 AU AU2001292905A patent/AU2001292905A1/en not_active Abandoned
- 2001-09-19 US US09/956,622 patent/US20030091973A1/en not_active Abandoned
- 2001-09-19 WO PCT/US2001/029548 patent/WO2002024943A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20030091973A1 (en) | 2003-05-15 |
WO2002024943A3 (en) | 2003-08-07 |
WO2002024943A9 (en) | 2003-04-03 |
WO2002024943A2 (en) | 2002-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001234608A1 (en) | Methods for analysis of gene expression | |
AU2001278783A1 (en) | Method of amplifying nucleic acid | |
AU2001240563A1 (en) | Detection of differential gene expression | |
AU2002321549A1 (en) | Method of providing information | |
AU2002214126A1 (en) | Genetic analysis of microorganisms | |
AU2002222618A1 (en) | Method of analyzing gene expression | |
AU2261802A (en) | Method of analyzing gene expression | |
AU2001278135A1 (en) | Method of identifying immunosuppressive agents | |
AU2928400A (en) | Analysis of differential gene expression | |
AU2001249065A1 (en) | Method of identifying toxic agents using differential gene expression | |
AU2002252560A1 (en) | Method of identifying renalgenerative agents using differential gene expression | |
AU2001247444A1 (en) | Erbeta-mediated gene expression | |
AU2001292905A1 (en) | Method of identifying osteoregenerative agents using differential gene expression | |
EP1165825A4 (en) | Toxicant-induced differential gene expression | |
AU2002221104A1 (en) | Method of detecting relation between genes | |
AU2002221638A1 (en) | Method for establishing germ cell-specific gene expression | |
AU1788601A (en) | Method of identifying toxic agents using nsaid-induced differential gene expression in liver | |
AU2002324232A1 (en) | Differential gene expression in schizophrenia | |
AU2001257591A1 (en) | Methods of identifying integrin ligands using differential gene expression | |
AU2001292468A1 (en) | Methods and means of rna analysis | |
AU2001286218A1 (en) | Method of judging gene mutation | |
AU2001293018A1 (en) | Application of bioinformatics for direct study of unculturable microorganisms | |
AU2002213695A1 (en) | Method of genomic analysis | |
AU2002222693A1 (en) | Method of concentrating gene | |
AU2002221076A1 (en) | Method of clustering genes |